Skip to main content

Emmes Studies Contribute to FDA Approval of a Medical Device That Estimates the Weight of Infants – BioHealth Capital Region

By January 20, 2020News
emmes logo

emmes logo

Emmes today announced that the U.S. Food and Drug Administration (FDA) has approved a prescription-only medical device used to estimate the weight of infants who are up to 90 days of age.

The Mercy babyTAPE is a tape-measure-like device that permits health care professionals to estimate the body weight of preterm and full-term infants when a scale may not be available or practical to use. Accurately estimating pediatric patient weight is important for drug dosing, resuscitation interventions, and nutritional assessments. This easy-to-produce device could be especially useful in emergency or resource-constrained situations such as remote or rural areas, and in developing countries.

 

{iframe}http://www.biohealthcapital.com/news/emmes-studies-contribute-to-fda-approval-of-a-medical-device-that-estimates-the-weight-of-infants/?utm_source=dlvr.it&utm_medium=linkedin{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.